CD8A and benign prostatic hyperplasia: Subdividing CD3+ T cells into CD4+ and CD8+ T cells revealed a strong decrease of CD4:CD8 ratio in BPH tissue compared to PBMCs (0.6 vs. 1.7) (Table 2).